S. 898

Referred to Committee

Fair Accountability and Innovative Research Drug Pricing Act of 2021

Introduced 3/23/2021•117th Congress•Senate

Congress.gov

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

3/23/2021 • Senate

Summary

Fair Accountability and Innovative Research Drug Pricing Act of 2021

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

Introduced in Senate • 3/23/2021

Enter your district to see how this bill affects your community

Topics & Subjects

Policy Area: Health

Business recordsCivil actions and liabilityCongressional oversightConsumer affairsCorporate finance and managementGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceInflation and pricesManufacturingMarketing and advertisingMedical researchPrescription drugsResearch and development